Journal: Transfusion Medicine and Hemotherapy
Submission Deadline: September 30, 2025
Feto-maternal incompatibilities represent a significant challenge in obstetric medicine, requiring close collaboration between various medical disciplines including transfusion medicine, obstetrics, neonatology, and immunohematology. Since the first description of hemolytic disease of the newborn, our understanding of feto-maternal incompatibilities has evolved tremendously. Today, we have access to sophisticated diagnostic tools and therapeutic options, enabling more precise risk assessment and management during pregnancy and after delivery.
For an article collection in Transfusion Medicine and Hemotherapy entitled ‘Feto-Maternal Incompatibilities’ we are looking for review and original papers. The aim of this article collection is to compile current research results and comprehensive reviews that deal with the complex interactions between maternal antibodies and fetal antigens, their clinical effects, and modern therapeutic approaches.
We particularly welcome contributions addressing:
- Current developments in antibody diagnostics and monitoring
- Non-invasive prenatal testing and detailed antibody characterization
- Novel insights into pathomechanisms of feto-maternal incompatibilities
- Advanced therapeutic strategies
- Prevention strategies and risk assessment
- Clinical management guidelines and recommendations
- Long-term outcomes and follow-up studies
- Immunological aspects of pregnancy
- Laboratory aspects of antibody detection and characterization
Please select the option “Call for Papers: Feto-Maternal Incompatibilities” when submitting your manuscript and mention this Call for Papers in your cover letter.
Karger has established agreements with consortia and institutions that include full or partial coverage of Article Processing Charges (APC). Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.
Check out the Author Guidelines.